Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production
- 1 December 1996
- journal article
- review article
- Published by Wiley in Journal of Medical Virology
- Vol. 50 (4) , 283-288
- https://doi.org/10.1002/(sici)1096-9071(199612)50:4<283::aid-jmv1>3.0.co;2-4
Abstract
No empirical data are available for the anti‐HBs titre required for protection against infection with the hepatitis B virus (HBV), but nonresponders to hepatitis B vaccines remain susceptible to infection. There may be an unexplained qualitative difference between hyporesponders and true nonresponders, but there is a clear association with HLA haplotypes. There is no evidence for silent infection with HBV in nonresponders.Keywords
This publication has 39 references indexed in Scilit:
- Hepatitis B vaccine boosting: the debate continuesThe Lancet, 1995
- Hepatitis B vaccination: protection for how long and against what?BMJ, 1993
- Acquired forms of immunosuppressionJournal of the American Academy of Dermatology, 1991
- Protective potential of hepatitis B virus antigens other than the S gene proteinVaccine, 1990
- Genetic Prediction of Nonresponse to Hepatitis B VaccineNew England Journal of Medicine, 1989
- Is booster injection with hepatitis B vaccine necessary in healthy responders?Journal of Hepatology, 1989
- Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual MenNew England Journal of Medicine, 1986
- Hepatitis B Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 1984
- Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populationsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- THYMOPENTIN AS ADJUVANT IN NON-RESPONDERS OR HYPORESPONDERS TO HEPATITIS B VACCINATIONThe Lancet, 1983